AML and chronic myelogenous leukemia (CML) cells in the acute phase also showed increased expression levels for DNMT1, DNMT3A and DNMT3B when compared to normal bone marrow cells. This evidence concerns the gene DNMT3A and chronic myelogenous leukemia, BCR-ABL1 positive.